Third, our study is incapable of answering how these circulating M-MDSCs from DLBCL patients express a higher surface TREM2, as upstream signals originating from the tumor site must play the key tune, and this warrants further investigation by bioinformatics analyses [40]. This evidence concerns the gene TREM2 and diffuse large B-cell lymphoma.